87 related articles for article (PubMed ID: 24012972)
1. Potential drug interventions for diabetic retinopathy.
Shen Q; Wu JZ; Wong JC
Drug Discov Today; 2013 Dec; 18(23-24):1334-41. PubMed ID: 24012972
[TBL] [Abstract][Full Text] [Related]
2. Editorial: possible therapeutic targets for the treatment of diabetic retinopathy: evidences from experimental models.
de Faria JM; Duarte DA
Curr Clin Pharmacol; 2013 Nov; 8(4):265. PubMed ID: 23173955
[No Abstract] [Full Text] [Related]
3. Epigenetic modifications as potential therapeutic targets in age-related macular degeneration and diabetic retinopathy.
Kwa FA; Thrimawithana TR
Drug Discov Today; 2014 Sep; 19(9):1387-93. PubMed ID: 24717156
[TBL] [Abstract][Full Text] [Related]
4. Models of retinal diseases and their applicability in drug discovery.
Malek G; Busik J; Grant MB; Choudhary M
Expert Opin Drug Discov; 2018 Apr; 13(4):359-377. PubMed ID: 29382242
[TBL] [Abstract][Full Text] [Related]
5. Connection of pericyte-angiopoietin-Tie-2 system in diabetic retinopathy: friend or foe?
Cai J; Ruan Q; Chen ZJ; Han S
Future Med Chem; 2012 Nov; 4(17):2163-76. PubMed ID: 23190105
[TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
7. Targeting the kallikrein-kinin system as a new therapeutic approach to diabetic retinopathy.
Pruneau D; Bélichard P; Sahel JA; Combal JP
Curr Opin Investig Drugs; 2010 May; 11(5):507-14. PubMed ID: 20419596
[TBL] [Abstract][Full Text] [Related]
8. Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in patients with severe nonproliferative or non-high-risk proliferative diabetic retinopathy: a randomized clinical trial.
Scott IU; Jackson GR; Quillen DA; Larsen M; Klein R; Liao J; Holfort S; Munch IC; Gardner TW
JAMA Ophthalmol; 2014 May; 132(5):535-43. PubMed ID: 24604308
[TBL] [Abstract][Full Text] [Related]
9. Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications.
Simó R; Hernández C;
Br J Ophthalmol; 2012 Oct; 96(10):1285-90. PubMed ID: 22887976
[TBL] [Abstract][Full Text] [Related]
10. [Kallikrein-kinin system as a target for diabetic retinopathy treatment].
Iarovaia GA; Neshkova EA; Blokhina TB; Kochergin SA; Vorob'eva IV; Gigineishvili DN
Vestn Oftalmol; 2012; 128(4):78-81. PubMed ID: 22994115
[TBL] [Abstract][Full Text] [Related]
11. Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals.
Robinson R; Barathi VA; Chaurasia SS; Wong TY; Kern TS
Dis Model Mech; 2012 Jul; 5(4):444-56. PubMed ID: 22730475
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors for diabetic retinopathy: the Korea National Health and Nutrition Examination Survey 2008-2011.
Jee D; Lee WK; Kang S
Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6827-33. PubMed ID: 24065813
[TBL] [Abstract][Full Text] [Related]
13. Current nanotechnology approaches for the treatment and management of diabetic retinopathy.
Fangueiro JF; Silva AM; Garcia ML; Souto EB
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):307-22. PubMed ID: 25536109
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of diabetic retinopathy in rural China: the Handan Eye Study.
Wang FH; Liang YB; Zhang F; Wang JJ; Wei WB; Tao QS; Sun LP; Friedman DS; Wang NL; Wong TY
Ophthalmology; 2009 Mar; 116(3):461-7. PubMed ID: 19168222
[TBL] [Abstract][Full Text] [Related]
15. [Diabetes self-management and its association with diabetic retinopathy in patients with type 2 diabetes].
Li N; Yang XF; Deng Y; Gu H; Ren XT; Xu J; Ma K; Liu NP
Zhonghua Yan Ke Za Zhi; 2013 Jun; 49(6):500-6. PubMed ID: 24119962
[TBL] [Abstract][Full Text] [Related]
16. Thailand diabetes registry project: prevalence of diabetic retinopathy and associated factors in type 1 diabetes mellitus.
Chetthakul T; Likitmaskul S; Plengvidhya N; Suwanwalaikorn S; Kosachunhanun N; Deerochanawong C; Krittiyawong S; Leelawatana R; Benjasuratwong Y; Bunnag P; Prathipanawatr T; Ngarmukos C; Mongkolsomlit S; Rawdaree P
J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S17-26. PubMed ID: 17715830
[TBL] [Abstract][Full Text] [Related]
17. Diabetic retinopathy: an Indian perspective.
Rema M; Pradeepa R
Indian J Med Res; 2007 Mar; 125(3):297-310. PubMed ID: 17496357
[TBL] [Abstract][Full Text] [Related]
18. Animal Models of Diabetic Retinopathy.
Jiang X; Yang L; Luo Y
Curr Eye Res; 2015; 40(8):761-71. PubMed ID: 25835487
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service.
Thomas RL; Dunstan FD; Luzio SD; Chowdhury SR; North RV; Hale SL; Gibbins RL; Owens DR
Br J Ophthalmol; 2015 Jan; 99(1):64-8. PubMed ID: 25091950
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence and risk factors of diabetic retinopathy in children and young adults].
Ben Hamouda H; Messaoud R; Grira S; Ayadi A; Khairallah M; Soua H; Sfar MT
J Fr Ophtalmol; 2001 Apr; 24(4):367-70. PubMed ID: 11351208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
